Document is current
Any future updates will be listed below
-
Authors
Ward, Sarah V.
Burton, Anya
Tamimi, Rulla M.
Pereira, Ana
Garmendia, Maria Luisa
Pollan, Marina
Boyd, Norman
dos-Santos-Silva, Isabel
Maskarinec, Gertraud
Perez-Gomez, Beatriz
Vachon, Celine
Miao, Hui
Lajous, Martín
López-Ridaura, Ruy
Bertrand, Kimberly
Kwong, Ava
Ursin, Giske
Lee, Eunjung
Ma, Huiyan
Vinnicombe, Sarah
Moss, Sue
Allen, Steve
Ndumia, Rose
Vinayak, Sudhir
Teo, Soo-Hwang
Mariapun, Shivaani
Peplonska, Beata
Bukowska-Damska, Agnieszka
Nagata, Chisato
Hopper, John
Giles, Graham
Ozmen, Vahit
Aribal, Mustafa Erkin
Schüz, Joachim
Van Gils, Carla H.
Wanders, Johanna O. P.
Sirous, Reza
Sirous, Mehri
Hipwell, John
Kim, Jisun
Lee, Jong Won
Dickens, Caroline
Hartman, Mikael
Chia, Kee-Seng
Scott, Christopher
Chiarelli, Anna M.
Linton, Linda
Flugelman, Anath Arzee
Salem, Dorria
Kamal, Rasha
McCormack, Valerie
Stone, Jennifer
-
Funding
Funding for this research was provided by:
Cancer Council Western Australia (Capacity Building and Collaboration Grant)
National Cancer Institute (R03CA167771)
International Agency for Research on Cancer
The University of Western Australia (Research Collaboration Award)
- License Information
-
More Information
Article History
Received: 7 February 2022
Accepted: 29 June 2022
First Online: 14 July 2022
Declarations
:
: Ethics approvals for ICMD were obtained from the International Agency for Research on Cancer (IEC 12 ± 34). Each individual study obtained informed consent to participate from women included in the study and had received local ethical approval at the time of the original conduct of the study and again to contribute to the consortium.
: Not applicable.
: ML declares a non-restricted investigator-initiated grant from AstraZeneca and minor support from Swiss Re.
